Trials / Conditions / Metabolic Syndrome X

Metabolic Syndrome X

187 registered clinical trials studyying Metabolic Syndrome X — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patient NCT06661655	E-Scopics	N/A
Recruiting	Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correla NCT06801769	Catholic University of the Sacred Heart	N/A
Recruiting	Identification of a Score for the Assessment of Intrapancreatic Fat NCT07155473	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	N/A
Recruiting	Home Blood Pressure Variability and Its Link to Arteriosclerosis and Metabolic Dysfunction in Hypertensive Pat NCT06394934	Korea University Anam Hospital	—
Recruiting	Lifestyle Changes in Older Adults With Metabolic Syndrome and Tinnitus NCT06702085	Cairo University	N/A
Completed	Effect of Blood Flow Restriction on Cardiovascular Function in Elderly with Metabolic Syndrome X NCT06877130	Cairo University	N/A
Recruiting	Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP) NCT06650943	Hospital de Basurto	N/A
Completed	Metabolic Syndrome and Related Diseases in Healthcare Workers NCT06543706	Peking Union Medical College Hospital	—
Completed	A Study on the Intervention of Metabolic Syndrome Patients With Exercise Prescription Based on Ventilatory Thr NCT06379204	Taiyuan Central Hospital of Shanxi Medical University	N/A
Completed	Evaluation of Clinical, Metabolic, and Physical-functional Effects of Systemic Vibratory Therapy in Metabolic NCT06907108	Laboratorio de Vibraçoes Mecanicas e Praticas Integrativas	N/A
Completed	Effect of Meat and Egg on TMAO in Plasma and Urine in Subjects with and Metabolic Subjects NCT06660251	Linnaeus University	N/A
Completed	Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss Durin NCT06641596	Kerry Group P.L.C	N/A
Completed	Berberine as Adjuvant Treatment for Schizophrenia Patients NCT02983188	The University of Hong Kong	Phase 2 / Phase 3
Completed	The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia NCT03856606	University of Texas at Austin	N/A
Completed	Therapeutic Efficacy of Phytosterols on Metabolic Syndrome NCT02969720	Universidad de los Andes, Chile	N/A
Completed	Description of an Immune Activation Profile Linked to Insulin Resistance in Subjects Aged 55-69 NCT03309761	Centre Hospitalier Universitaire de Nīmes	—
Unknown	Impact of Interventions With a Diet and Exercise on the Cardio-metabolic Status in Multi-risk Population NCT03701425	Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado	N/A
Unknown	Effect of Food Consumption on microRNA Related to Metabolic Syndrome NCT02606812	Universidad Juárez Autónoma de Tabasco	N/A
Completed	Mechanisms of Cerebrovascular Control NCT02936687	University of Wisconsin, Madison	Phase 1
Completed	Exercise Training and Hepatic Metabolism in Overweight/Obese Adolescent NCT02753231	Universidad Santo Tomas	N/A
Completed	Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects NCT03310359	University of California, San Diego	N/A
Completed	Diet and Exercise Interventions to Increase Muscle Strength and Function NCT02850562	South Dakota State University	N/A
Completed	Impact of Meal Order on Postprandial Cardiometabolic Risk Markers NCT03358745	Lund University	N/A
Completed	Evaluation of the Effects of a L.Reuteri Strain on Markers of Inflammation, Cardiovascular Risk and Fatty Live NCT02972567	Biosearch S.A.	N/A
Unknown	Nutrition and Lifestyle Behaviour Peer Support Program Among Malaysian Adults With Metabolic Syndrome (PERSUAD NCT03417128	Monash University	N/A
Completed	Metabolic Risk Management, Physical Exercise and Lifestyle Counselling in Low-active Adults; Controlled Random NCT02832453	INEFC-Lleida	N/A
Completed	Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome NCT02672592	University Hospital, Basel, Switzerland	Phase 3
Completed	Low Fat Plant-Based Supplemented Diet Effects on Risk Factors for Chronic Non-communicable Diseases NCT02905448	Barbara Jakše s.p.	N/A
Unknown	Is Health Coaching Effective for Improving Metabolic Health in People With Psychosis Disorders? NCT01752465	University of British Columbia	N/A
Completed	Evaluation of the Effects Associated With the Administration of Akkermansia Muciniphila on Parameters of Metab NCT02637115	Patrice D. Cani	N/A
Unknown	The Effects of Beta-glucan Enriched Oatcake Consumption on Metabolic Disease Risk Factors NCT02615444	Queen Margaret University	N/A
Completed	Effects of a Standardized Freeze-dried Grape Powder on High Density Lipoprotein (HDL) Function in Metabolic Sy NCT02542176	University of Connecticut	N/A
Unknown	Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases NCT02702375	University of Toronto	—
Completed	Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption NCT02918422	Ohio State University	N/A
Completed	Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome NCT02649348	Qingdao University	N/A
Completed	Effects of TA-65, a Telomerase Activator on Metabolic Syndrome NCT02531334	University of Connecticut	N/A
Completed	Exercise Training Effects on Metabolic Syndrome: Interactions With Medication NCT03019796	University of Castilla-La Mancha	EARLY_Phase 1
Unknown	EFFECT OF Salvia Hispanica l. (CHIA) IN THE BIOCHEMICAL METABOLIC SYNDROME COMPONENTS NCT02480673	Instituto Mexicano del Seguro Social	N/A
Completed	Study of Chronic Degenerative Diseases NCT02495961	Asociación Científica Latina A.C.	—
Completed	Periodized Aerobic Interval Training in Metabolic Syndrome NCT03119493	Universidade Estadual Paulista Júlio de Mesquita Filho	N/A
Unknown	The Metabolic Syndrome Among Leukemia Survivors: Physiopathological Analysis NCT02696304	Assistance Publique Hopitaux De Marseille	N/A
Recruiting	The Early Warning System for the Diabetic Encephalopathy NCT02420470	Tang-Du Hospital	—
Unknown	Activating Brown Adipose Tissue Through Exercise NCT02365129	Universidad de Granada	N/A
Completed	Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity NCT02767869	University of Guadalajara	Phase 2
Completed	Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity NCT02354339	University of Guadalajara	N/A
Completed	Individual Metabolism and Physiology Signature Study NCT02298725	USDA, Western Human Nutrition Research Center	N/A
Completed	Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults NCT02347007	Columbia University	N/A
Completed	Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome NCT02337933	University of Guadalajara	Phase 2
Completed	Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos (E-LITE Latinos) NCT02459691	Palo Alto Medical Foundation	N/A
Completed	Effect of a Low Glycemic Index on Metabolic Syndrome NCT02356952	Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis	N/A
Completed	The Improvements of Dietary Supplement of Black Rice on Metabolic Syndrome NCT02407522	Sun Yat-sen University	Phase 2 / Phase 3
Terminated	Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients NCT02174783	The Cleveland Clinic	N/A
Completed	Magnesium and Metabolic Syndrome: A Dose-response Meta-analysis NCT02151227	The Catholic University of Korea	—
Completed	Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome NCT02605655	Shanghai University of Traditional Chinese Medicine	EARLY_Phase 1
Completed	Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion NCT02113241	University of Guadalajara	Phase 2 / Phase 3
Unknown	Female Subfertility: a Metabolic and Vascular Profile NCT02136472	Maastricht University Medical Center	—
Unknown	Maternal Hypertriglyceridaemia Study NCT02479113	University of Malaya	—
Unknown	MEPHISTO (Macrophage Phenotype In Metabolic Syndrome With Iron Overload) NCT02066012	University Hospital, Clermont-Ferrand	—
Completed	Effect of Two Diets With Different Content of Protein on Weight Loss in Adults With Metabolic Syndrome NCT02278757	Mexican National Institute of Public Health	N/A
Completed	The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study) NCT02035592	University of East Anglia	N/A
Completed	Metformin in the Diastolic Dysfunction of Metabolic Syndrome NCT02017561	Universidade do Porto	Phase 2
Completed	Effect of Dietary Flavonoids on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome NCT02728570	Utah State University	N/A
Completed	Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics NCT02402985	German Institute of Human Nutrition	N/A
Completed	Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis NCT01849068	Laval University	Phase 3
Completed	Probiotic Bacteria in Prevention of the Metabolic Syndrome NCT02288572	University Maribor	Phase 2
Completed	Dairy Products and Metabolic Syndrome NCT01913756	Norwegian University of Life Sciences	N/A
Completed	Recreational Physical Activity and Cardiometabolic Profile NCT02982967	Federal University of São Paulo	N/A
Completed	Effects of Wine Grape Pomace Flour Used as a Dietary Supplement on Metabolic Syndrome Components NCT02202863	Pontificia Universidad Catolica de Chile	N/A
Completed	Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue NCT01794429	Bjorn H. Ebdrup	Phase 3
Completed	Multimodal Intervention Program for Patients With Metabolic Syndrome NCT02949622	Universidad de Granada	N/A
Completed	Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI NCT01739127	University of British Columbia	—
Unknown	The Effects of High-intensity Aerobic Training in Patients With Metabolic Syndrome NCT02130336	National Taiwan University Hospital	N/A
Completed	Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health NCT02042274	University of Guelph	N/A
Completed	Soy Protein Intake and the Metabolic Syndrome NCT01694056	Wageningen University	N/A
Completed	Functional MRI Biomarkers of Cognitive Decrements in Diabetes NCT01705210	Maastricht University Medical Center	—
Completed	Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion NCT02114892	University of Guadalajara	Phase 2
Completed	Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study NCT01465620	Henri Mondor University Hospital	Phase 3
Completed	OPUS School Meal Study - Cross Sectional Analyses From Baseline Investigations NCT01577277	Arne Astrup	—
Completed	OPUS School Meal Study NCT01457794	Arne Astrup	N/A
Terminated	Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity NCT01351753	University of Iowa	Phase 2
Completed	Reducing Disparities in Late Life Depression and Metabolic Syndrome NCT01428791	Rush University Medical Center	N/A
Completed	Effects of Medium-Chain Triglycerides on Chylomicron Secretion and Expression of Genes That Regulate Intestina NCT01806142	Laval University	N/A
Completed	Environmental Triggers Of Cardiometabolic Disease NCT01548300	Sanjay Rajagopalan	—
Completed	Soy Nut Study on Markers of Health NCT01173380	University of California, Davis	N/A
Completed	OPTIFIT-Optimal Fiber Trial for Diabetes Prevention NCT01681173	German Institute of Human Nutrition	N/A
Completed	Physical Activity on Prescription in Patients With Metabolic Risk Factors. NCT03012516	Vastra Gotaland Region	N/A
Completed	Predictors of Increased Physical Activity in Patients Receiving Physical Activity on Prescription NCT03586011	Vastra Gotaland Region	—
Completed	Exercise and Technology to Reduce Risk in a Rural Population With Metabolic Syndrome NCT01944124	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	N/A
Completed	Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome NCT00956189	National Taiwan University Hospital	N/A
Completed	Brown Rice Intervention on Metabolic Syndrome (BRIMS) NCT01022411	Chinese Academy of Sciences	Phase 2 / Phase 3
Completed	Efficacy of a Prebiotic Galactooligosaccharide to Reduce Metabolic Syndrome Risk Factors in Overweight Adults NCT01004120	Clasado	Phase 1 / Phase 2
Completed	Study of the Relationships Between Apolipoprotein B-48 Kinetics and Expression of Genes That Regulate Intestin NCT01829945	Laval University	—
Completed	Frequency of Metabolic Syndrome in Down Syndrome Patients NCT00864461	Universidad de Guanajuato	—
Completed	Metabolic Syndrome in Patients With First-episode Schizophrenia NCT00957294	Aarhus University Hospital	—
Withdrawn	Physical Inactivity and Insulin Resistance in Skeletal Muscle. NCT00536211	University of Kansas Medical Center	N/A
Completed	Prevalence of Metabolic Syndrome in Patients With Intermittent Claudication NCT00946868	University of Sao Paulo	—
Completed	Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects NCT01145066	Wake Forest University Health Sciences	Phase 2
Completed	Flaxseed Intervention on Metabolic Syndrome NCT00733772	Chinese Academy of Sciences	Phase 2 / Phase 3
Completed	Walnut Intervention on Metabolic Syndrome (WIMS) NCT00742742	Chinese Academy of Sciences	Phase 2 / Phase 3
Completed	Effect of Fish Oil on Insulin Sensitivity NCT01241474	University of Aberdeen	N/A
Completed	Effects of Dietary Proteins on Hepatic Lipid Metabolism NCT00558740	University of Lausanne	—
Completed	Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity NCT01806506	Medical University of Warsaw	N/A
Unknown	High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome NCT00716300	The University of Western Australia	—
Completed	Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome NCT00671515	Joseph Calabrese, MD	Phase 2
Terminated	Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopaus NCT00663104	University of Erlangen-Nürnberg Medical School	Phase 3
Completed	A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes NCT00675857	Bellus Health Inc. - a GSK company	Phase 2
Completed	Effects of High-fat and Low-fat Diet on the Gut NCT00561626	Maastricht University Medical Center	N/A
Unknown	Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors NCT00566566	Sheba Medical Center	—
Unknown	Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness NCT00573950	Korea University Anam Hospital	Phase 4
Completed	An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antips NCT00448630	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	—
Completed	The Metabolic Effects of Different Weight Loss Diets NCT00422630	Rockefeller University	N/A
Completed	Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort NCT00344903	University of Texas Southwestern Medical Center	—
Completed	Effect of Exercise Training on the Function of the High Density Lipoprotein (HDL)-Cholesterol, Endothelial Fun NCT00515476	Hannover Medical School	N/A
Completed	Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen NCT00613314	Boehringer Ingelheim	—
Completed	Diurnal Variation of Plasminogen Activator Inhibitor-1 NCT00515021	Vanderbilt University Medical Center	Phase 4
Unknown	The Study of Metabolic Syndrome in Hemodialysis Patients NCT00632879	Far Eastern Memorial Hospital	—
Completed	Cardiovascular Disease Risk Factors in Chinese American Immigrants NCT00362128	Albert Einstein College of Medicine	—
Completed	Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation NCT00470262	VA Office of Research and Development	N/A
Completed	Lifestyle Modification and Metformin Use in the Treatment of HIV NCT00399360	Massachusetts General Hospital	N/A
Completed	MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study NCT00405197	Wageningen University	N/A
Completed	Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging NCT00401336	Rennes University Hospital	N/A
Completed	Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome NCT00272311	Florida Atlantic University	Phase 4
Completed	Effects of NUTRIOSE®FB Dietary Fiber Supplementation on Satiety, Body Fat, and Metabolic Syndrome in Overweigh NCT01044680	Roquette Freres	Phase 2 / Phase 3
Unknown	The Effects of Omega-3 Fatty Acids on Metabolic Syndrome NCT00350194	University of Washington	EARLY_Phase 1
Completed	ROMEO (Rosuvastatin in Metabolic syndrOme) NCT00395486	AstraZeneca	Phase 4
Completed	Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrom NCT00362908	University of Washington	N/A
Unknown	Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study) NCT00408824	Nagoya University	—
Completed	Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity NCT00523562	University of Lausanne	N/A
Completed	Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes NCT00338949	Veterans Medical Research Foundation	Phase 4
Terminated	Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity NCT00608465	Vanderbilt University	Phase 4
Completed	ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome NCT00489333	Health Enhancement Products, Inc.	N/A
Completed	Biological Efficacy of Clopidogrel After Implantation of Drug-eluting Stents (SPACE) NCT00298428	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults NCT00318734	University of North Carolina, Chapel Hill	—
Completed	Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) NCT00455403	Washington University School of Medicine	N/A
Completed	Effects the Glycemic Index on Metabolic Risk Markers NCT00695825	Maastricht University Medical Center	N/A
Completed	Side Effects of Antipsychotic Medications NCT00363181	Stanford University	—
Completed	Collaborative Care for Heart Failure Patients With the Metabolic Syndrome NCT00293852	Baylor College of Medicine	N/A
Terminated	Rosiglitazone Versus Placebo in Chronic Stable Angina NCT00225355	University of Glasgow	Phase 4
Completed	Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia NCT00327054	Aga Khan University	Phase 1 / Phase 2
Completed	A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism NCT00327002	University of Pennsylvania	Phase 2
Completed	Study In Patients With Dyslipidaemia NCT00264667	GlaxoSmithKline	Phase 2
Completed	Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities NCT00242814	Boehringer Ingelheim	Phase 4
Completed	PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metaboli NCT00296803	Sanofi	Phase 4
Completed	Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin Sens NCT00545805	University of Campinas, Brazil	Phase 2 / Phase 3
Completed	Dairy Products and Metabolic Effects (Norwegian Part) NCT00140816	Oslo University Hospital	N/A
Terminated	Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant NCT00228176	Sanofi	Phase 3
Completed	Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese NCT00119795	Wake Forest University Health Sciences	N/A
Completed	The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty Acids NCT00184899	Radboud University Medical Center	N/A
Completed	The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study NCT00400231	University of Pennsylvania	Phase 2
Completed	The Effects of Cilnidipine on Metabolic Syndrome Improvement NCT00325936	Boryung Pharmaceutical Co., Ltd	Phase 4
Completed	Oral Contraceptives in the Metabolic Syndrome NCT00205504	Virginia Commonwealth University	Phase 4
Suspended	Insulin Resistance Study NCT00614757	Midwest Biomedical Research Foundation	N/A
Unknown	Sympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle Interventions NCT00163943	Bayside Health	N/A
Unknown	Pancreatic Islet Function, Insulin Sensitivity, and Chronic Complications in Pre-Diabetes NCT00172796	National Taiwan University Hospital	—
Suspended	Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome NCT00243984	Northeastern Ohio Universities College of Medicine	Phase 3
Completed	The Effect of Diet and Exercise in Heart Failure NCT00297154	Baylor College of Medicine	N/A
Completed	Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance NCT00130286	Weill Medical College of Cornell University	Phase 1 / Phase 2
Completed	Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons NCT00194428	Temple University	Phase 1 / Phase 2
Completed	20 Year Changes in Fitness & Cardiovascular Disease Risk - Ancillary to CARDIA NCT00106457	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome NCT00129792	Oregon Health and Science University	N/A
Unknown	Evaluation of Effect of Exercise on Prescription NCT00399997	University of Southern Denmark	Phase 2 / Phase 3
Unknown	a Population Based Study on Metabolic Syndrome Complications, and Mortality NCT02958579	Tehran University of Medical Sciences	—
Unknown	The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy Balance NCT00172614	National Taiwan University Hospital	—
Unknown	Comparison of Two Different Diets on Health Outcomes NCT00269646	University of Virginia	N/A
Completed	Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers NCT00175084	Tufts University	N/A
Completed	Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells NCT00166036	Emory University	Phase 2
Completed	Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) NCT00455325	Washington University School of Medicine	Phase 2
Completed	Partnership Programs to Reduce Ethnic Differences in the Risk of Cardiovascular Disease NCT00101517	Emory University	—
Completed	Inflammatory Profiles of Children at High Risk for Atherosclerosis NCT00115232	Boston Children's Hospital	—
Completed	Effects of Resistance and Aerobic Exercise on Cardiovascular Health NCT00275145	Duke University	Phase 2
Completed	Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial NCT00147264	McMaster University	Phase 3
Completed	Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome NCT00111956	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 2 / Phase 3
Completed	The Effects of Aripiprazole on Patients With Metabolic Syndrome NCT00224822	New Mexico VA Healthcare System	Phase 4
Completed	Effect of Vegetable Oils for Use by the Snack Food Industry on Plasma Lipid Levels and Inflammatory Markers NCT00175071	Tufts University	N/A
Completed	Chromium Picolinate for the Treatment of Metabolic Syndrome NCT00128154	National Center for Complementary and Integrative Health (NCCIH)	N/A
Unknown	Health of Young European Families and Fish Consumption NCT00315770	Landspitali University Hospital	Phase 1
Completed	Genomewide Search for Loci Underlying Metabolic Syndrome NCT00074451	National Heart, Lung, and Blood Institute (NHLBI)	—
Unknown	Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress NCT00177892	National Institute on Aging (NIA)	N/A
Completed	Epidemiology of Stress and the Metabolic Syndrome NCT00073775	University of Florida	—
Completed	Inflammation and the Metabolic Syndrome in Humans NCT00954824	University of Pennsylvania	N/A
Completed	Weight Loss in Diabetic, Older Obese Adults NCT00108329	US Department of Veterans Affairs	N/A
Completed	Genetic Determinants:Low HDL, High Triglycerides, Obesity NCT00049881	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia NCT00304993	Foundation Research, Florida	Phase 4
Completed	Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I) NCT00200993	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2
Completed	Genetics of the Metabolic Syndrome in Japanese Americans NCT00005374	University of Washington	—
Completed	Central Obesity and Disease Risk in Japanese Americans NCT00005365	University of Washington	—
Completed	Behavioral Factors in Coronary Heart Disease NCT00005314	Duke University	—